1Weir HK, Thun MJ, Hankey BF, et al.Annual report to the nation on the status of cancer, 1975--2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst, 2003, 95(17) : 1276-1299.
2Weir HK, Thun MJ, Hankey BF, et al.Annual report to the nation on the status of cancer, 1975--2000, featuring the uses of surveillance data for cancer prevention and control.J Natl Cancer Inst,2003,95(21) : 1641.
3Jemal A, Thomas A, Murray T, et al.Cancer statistics, 2002. CA Cancer J Clin,2002, 52 (1) : 23-47.
4Jemal A, Thomas A, Murray T, et al.Cancer statistics, 2002.CA Cancer J Clin, 2002, 52 (2):119.
5Jemal A, Thomas A, Murray T, et al.Cancer statistics, 2002.CA Cancer J Clin,2002,52(3):181-182.
6Pieterman RM, van Putten JW, Meuzelaar J J, et al. Preoperative staging of non-small-cell lung cancer with positron-emission tomography. N Engl J Med, 2000,343(4) : 254-261.
8Delbeke D, Martin WH. Positron emission tomography imaging in oncology. Radiol Clin North Am,2001,39(5): 883-917.
9Ak I, Blokland JA, Pauwels EK, et al.The clinical value of 18F-FDG detection with a dual-head coincidence camera: a review. Eur J Nucl Med,2001,28(6) : 763-778.
10Nehmeh SA, Erdi YE, Pan T, et al. Four-dimensional (4D) PET/CT imaging of thethorax. Med Phys, 2004, 31(12 ) :3179-3186.
7Yuka Yamamoto,Yoshihiro Nishiyama,Toshihide Monden,Yasuhiro Sasakawa,Motoomi Ohkawa,Masashi Gotoh,Kotaro Kameyama,Reiji Haba. Correlation of FDG-PET findings with histopathology in the assessment of response to induction chemoradiotherapy in non-small cell lung cancer[J] 2006,European Journal of Nuclear Medicine and Molecular Imaging(2):140～147
8Dirk Hellwig,Andreas Gr?schel,Thomas P. Graeter,Anne P. Hellwig,Ursula Nestle,Hans-Joachim Sch?fers,Gerhard W. Sybrecht,Carl-Martin Kirsch. Diagnostic performance and prognostic impact of FDG-PET in suspected recurrence of surgically treated non-small cell lung cancer[J] 2006,European Journal of Nuclear Medicine and Molecular Imaging(1):13～21
